Academic Highlights: The Evolving Paradigm for Bipolar Disorder. [CME]
J Clin Psychiatry 2007;68(1):139-150
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Bipolar disorder is a recurrent illness, and treatment of bipolar disorder is challenging. Although no cure exists, effective acute and maintenance management of the illness can reduce morbidity and mortality associated with the illness. The following presentations by experts in the field address the selection of appropriate treatment for the acute and long-term management of bipolar disorder based on trial data for atypical antipsychotics and mood stabilizers.